au.\*:("HARMENBERG, U")
Results 1 to 10 of 10
Selection :
Serum levels of CA 19-9 and CA 50 in relation to Lewis blood cell status in patients with malignant and benign pancreatic diseaseVON ROSEN, A; LINDER, S; HARMENBERG, U et al.Pancreas. 1993, Vol 8, Num 2, pp 160-165, issn 0885-3177Article
Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tractHARMENBERG, U; WAHREN, B; WIECHEL, K.-L et al.Cancer research (Baltimore). 1988, Vol 48, Num 7, pp 1985-1988, issn 0008-5472Article
Search for epitopic sites of antibodies to germ cell alkaline phosphataseHARMENBERG, U; LJUNGDAHL-STAHLE, E; RUDEN, U et al.Cancer communications (New York, NY). 1991, Vol 3, Num 10-11, pp 305-311, issn 0955-3541Article
Identification and characterization of alkaline phosphatase isozymes in human colorectal adenocarcinomasHARMENBERG, U; KOHA, M; MAKIYA, R et al.Tumor biology. 1991, Vol 12, Num 4, pp 237-248, issn 1010-4283Article
Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000―2008)WAHLGREN, T; HARMENBERG, U; SANDSTRÖM, P et al.British journal of cancer. 2013, Vol 108, Num 7, pp 1541-1549, issn 0007-0920, 9 p.Article
T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myelomaFAGERBERG, J; YI, Q; GIGLIOTTI, D et al.International journal of cancer. 1999, Vol 80, Num 5, pp 671-680, issn 0020-7136Article
Tumour markers in gastrointestinal cancerWAHREN, B; HARMENBERG, U.Scandinavian journal of clinical & laboratory investigation. Supplement. 1991, Vol 51, Num 206, pp 21-27, issn 0085-591XConference Paper
Clinical effects of monoclonal antibodies (MAb 17-1A) in patients with metastatic colorectal carcinomasFRÖDIN, J.-E; HARMENBERG, U; BIBERFELD, P et al.Hybridoma. 1988, Vol 7, Num 4, pp 309-321, issn 0272-457XArticle
Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinomaMOSOLITS, S; HARMENBERG, U; RUDEN, U et al.Cancer immunology and immunotherapy. 1999, Vol 47, Num 6, pp 315-320, issn 0340-7004Article
Clonal CD8+ and CD52- T cells are induced in responding B cell lymphoma patients treated with campath-1H (anti-CD52)ÖSTERBORG, A; WERNER, A; HALAPI, E et al.European journal of haematology. 1997, Vol 58, Num 1, pp 5-13, issn 0902-4441Article